Clinical Cancer Bulletin
Springer Nature · Singapore
Aims & Scope✦ Inferred from recent articles
This journal focuses on advancements in cancer treatment and diagnosis, with a particular emphasis on immunotherapies like CAR-T cell therapy and tumor-infiltrating lymphocyte therapy, as well as AI-driven drug design and diagnostic techniques such as ultrasound-guided biopsies and liquid biopsies. The scope also includes research on specific cancers like lung, liver, and colorectal cancer, and the management of treatment-related adverse events.
AI-summarised from recent articles · verify on publisher page →
General Information
Submission Info
Ethics & Quality
Think.Check.Submit Compliance
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Subject Classification
Research Topics (OpenAlex)
Frequently asked questions about Clinical Cancer Bulletin
Is Clinical Cancer Bulletin a predatory journal?
PubScope has no integrity flags on record for Clinical Cancer Bulletin: it is indexed in DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 52/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.
What is the impact factor of Clinical Cancer Bulletin?
Clinical Cancer Bulletin is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor.
Is Clinical Cancer Bulletin indexed in Scopus and Web of Science?
Clinical Cancer Bulletin is indexed in DOAJ.
You May Also Like
See all →Data updated: 2026-05-26 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref